Why can the eye hurt more than it looks?
One of the most frustrating experiences in dry eye is this: your eyes hurt terribly, but someone examines them and says, “They don’t look that bad.”
Or the opposite happens. The cornea shows significant staining and tear-film abnormalities, yet the patient reports surprisingly little discomfort.
Because dry-eye symptoms are not produced by the tear film alone. To feel dryness, burning, pain, wind or temperature, the eye needs a sensory nervous system. And that nervous system can change.
The cornea contains a dense network of sensory nerves. These nerves detect many different kinds of stimuli, including:
This sensory system serves an important protective function. If something threatens the ocular surface, the nervous system can help trigger:
So corneal nerves are not simply the wires that make dry eye hurt. They are part of the system that helps maintain the ocular surface.
Imagine a stable tear film covering the cornea. Then part of that film becomes unstable and breaks. The exposed ocular surface experiences changing osmolarity, temperature, mechanical conditions and other stimuli. Corneal sensory nerves detect these changes. Signals travel through the trigeminal sensory system. The brain interprets those signals. You may experience:
That sensation is useful. It tells you that something is happening on the ocular surface.
Exactly. This distinction is extremely important. If the ocular surface is damaged or unstable and the nerves correctly signal that damage, that is nociceptive pain. There is a stimulus. The sensory system detects it. You feel discomfort or pain. That is not evidence that the nervous system itself is malfunctioning.
If someone has severe tear-film instability, corneal epithelial damage, significant inflammation or exposure, it is completely understandable that the eye hurts. We should not label every painful dry eye as neuropathic.
Neuropathic pain involves abnormal function or damage within the sensory nervous system itself. In corneal neuropathic pain, the nerves involved in ocular sensation may generate or amplify pain abnormally.
A 2024 clinical review describes it as an abnormal pain response that may involve peripheral mechanisms, central mechanisms, or both. This means the relationship between the ocular-surface stimulus and the perceived pain can become altered.
Imagine that corneal nerves have been repeatedly exposed to inflammation, injury, surgery, tear-film stress or another persistent stimulus. The peripheral sensory system can become more responsive. A stimulus that previously produced a small signal may now produce a much larger one. In simplified terms:
same stimulusstronger nerve responsemore pain
This is peripheral sensitization. The problem is still largely being generated in peripheral sensory pathways associated with the eye.
Pain signals do not stop at the cornea. They travel through the nervous system and are processed centrally. With persistent nociceptive input, processing within the central nervous system can also change. The system can become increasingly responsive to sensory signals. Now pain may no longer depend entirely on the amount of ongoing ocular-surface damage.
This is broadly what is meant by central sensitization. Reviews of corneal neuropathic pain describe both peripheral and central mechanisms, and the two can coexist.
No. This phrase creates enormous misunderstanding. All pain is processed by the nervous system. If central sensory processing changes, the resulting pain is still a real biological experience. The distinction is about where the pain signal is being generated or amplified, not whether the person is imagining it.
Allodynia means that a stimulus that normally should not be painful becomes painful. For someone with ocular pain, that might include severe discomfort triggered by something such as ordinary airflow or light.
A related term is hyperalgesia, where a genuinely painful stimulus produces an exaggerated pain response. These phenomena can occur when sensory pathways become sensitized.
No. This is very important. Wind increases evaporation. If your tear film is unstable, wind can genuinely increase ocular-surface stress. So “wind hurts my eyes” can be perfectly compatible with ordinary evaporative dry eye.
What becomes more interesting is when the severity or character of the response seems increasingly difficult to explain from the ocular-surface findings alone. Even then, it is a clue — not a diagnosis.
Light sensitivity can occur in several ocular conditions. It is also commonly reported in corneal neuropathic pain and may be particularly relevant when central sensitization is suspected. But again, photophobia does not automatically mean neuropathic pain. Other ocular and neurological causes need to be considered.
You may encounter this phrase frequently in discussions of neuropathic corneal pain. It describes a striking mismatch: severe symptoms but relatively little observable ocular-surface damage. Corneal neuropathic pain has therefore sometimes been described as “pain without stain.”
It is a memorable phrase. But it is not a diagnostic test. Someone can have severe dry-eye symptoms with relatively modest staining for many reasons. And someone with neuropathic pain can simultaneously have genuine dry-eye disease.
Yes. And this may be the most important concept in the entire article. This does not have to be dry eye or neuropathic pain. It can be dry eye and altered sensory processing.
Persistent ocular-surface damage or inflammation can provide repeated sensory input. Over time, peripheral and potentially central sensitization may develop. A 2024 clinical review specifically emphasizes that dry-eye disease and corneal neuropathic pain can coexist and that chronic ocular-surface injury may contribute to sensitization.
So treating one does not necessarily make the other disappear immediately.
Potentially, yes. Imagine the following sequence:
tear-film dysfunctionrepeated ocular-surface stresspersistent sensory inputsensitization
Now treatment improves the tear film. The original stimulus becomes much smaller. But the sensory system may not instantly return to its previous state. So a better ocular surface does not always produce immediate disappearance of symptoms.
That does not prove neuropathic pain. But it is one possible explanation when symptoms and signs begin to diverge.
Yes. Corneal nerve dysfunction does not always mean too much sensation. Sometimes corneal sensitivity can become reduced. This matters enormously because corneal sensation participates in reflex tearing, blinking, protective responses and maintenance of the ocular surface.
Severe loss of corneal innervation can contribute to neurotrophic keratopathy, where the cornea may become damaged while the patient experiences surprisingly little pain.
So nerve dysfunction can exist at both extremes: too much sensory signaling or too little protective sensation. This is another reason pain intensity alone cannot tell us how healthy the cornea is.
Yes. The cornea is innervated tissue, so procedures involving it can affect corneal nerves. Neuropathic corneal pain has been reported after procedures including refractive surgery and cataract surgery, as well as after ocular infection and other injuries.
Most people undergoing these procedures do not develop chronic neuropathic pain. But persistent pain following ocular surgery or infection is one situation in which clinicians may consider a neuropathic component.
This is where things become difficult. There is currently no single gold-standard diagnostic test. Diagnosis is based on the overall clinical picture. That may include:
But none of these alone can simply print out “neuropathic pain: yes or no.” The 2024 review emphasizes that standardized diagnostic criteria are still lacking and that even technologies such as confocal microscopy and esthesiometry cannot independently confirm the diagnosis.
Esthesiometry attempts to measure corneal sensitivity. Different devices can assess how strongly the cornea responds to controlled stimulation. This can help identify reduced sensation or altered sensory responses.
But corneal sensation is complex. One measurement cannot fully describe how the entire ocular sensory system is functioning. So esthesiometry can contribute information. It is not a standalone diagnosis.
In vivo confocal microscopy, or IVCM, allows clinicians and researchers to visualize microscopic structures within the living cornea, including corneal nerves. Studies have described changes such as altered nerve density, nerve morphology and nerve abnormalities in some patients with neuropathic corneal pain.
But these findings are not sufficiently specific to make IVCM a simple diagnostic yes/no test. Current reviews explicitly caution that IVCM may support the clinical assessment but cannot independently confirm corneal neuropathic pain.
This is an interesting clinical tool. A topical anesthetic such as proparacaine temporarily blocks peripheral sensory input from the ocular surface. Then the clinician asks what happened to the pain.
No. This distinction is essential. The test can help clinicians think about where pain may be generated or maintained. But it cannot reliably distinguish ordinary nociceptive dry-eye pain from every form of peripheral neuropathic pain. A management review specifically notes that topical anesthetic testing cannot by itself distinguish pathological dry-eye symptoms from peripheral neuropathic symptoms.
So again: a useful clue is not a definitive diagnosis.
Usually, that would be a mistake. A patient may have MGD plus ocular-surface inflammation plus peripheral sensitization, or aqueous deficiency plus epithelial damage plus central sensitization. The presence of a neural component does not magically make the tear-film disease disappear.
A 2024 clinical review recommends a thorough ocular assessment precisely because coexisting ocular-surface disease should be identified and treated. So treatment may need to address both sides of the problem: reduce ongoing peripheral stress and address abnormal pain processing when necessary.
Potentially. Reducing tear-film instability, inflammation, exposure and other sources of repeated nociceptive input makes biological sense because it reduces the stimulus continually reaching the sensory system.
Some treatments are also being investigated specifically for their potential effects on corneal nerve health. For example, autologous serum eye drops have been studied in neuropathic corneal pain with reports of improvement in symptoms and corneal nerve parameters. But the evidence remains much less mature than for many conventional dry-eye treatments, and standardized protocols and high-quality long-term trials are still needed.
There is no single established treatment that works for everyone. Management depends partly on whether the dominant mechanism appears peripheral, central or mixed. The first step is generally to identify and optimize any genuine ocular-surface disease. Depending on the individual situation, treatment may then involve:
When central mechanisms are important, multidisciplinary care involving specialists in pain medicine, neurology or other relevant fields may be needed.
Because the evidence is still developing. Corneal neuropathic pain is increasingly recognized, but compared with conditions such as conventional dry-eye disease, there are:
The 2024 clinical review specifically highlights the need for better clinical trials and registry data. So this is an area where we should be particularly cautious about online claims that one particular treatment “regenerates the nerves” or “cures neuropathic dry eye.” The science is not yet that simple.
It is worth investigating. But do not immediately conclude “Then it must be neuropathic.” First ask whether the testing actually captured the relevant problem. Dry eye can fluctuate enormously. One examination may miss:
Only after looking at the whole picture does the mismatch between signs and symptoms become clinically meaningful.
That deserves attention too. Reduced corneal sensation can mean the ocular surface is less capable of warning you about damage. In that situation, little pain does not necessarily mean little disease. This is particularly important in neurotrophic corneal disease.
Again, symptoms and damage are related — but they are not the same measurement.
Pain perception is influenced by the broader nervous system, and chronic pain can interact with sleep, stress, mood and many other aspects of physiology. But this must be discussed carefully. Finding an association between chronic ocular pain and anxiety or depression does not mean that the eye symptoms are imaginary or psychologically created.
A clinical review of corneal neuropathic pain recommends considering psychological health as part of a broader multidisciplinary assessment, particularly in chronic pain, while treating the condition as a genuine pain disorder. The nervous system is biological. Psychological state and biological pain processing are not mutually exclusive categories.
No. The word neuropathic can sound terrifying. But it does not automatically mean irreversible. Peripheral sensory abnormalities may improve, particularly when ongoing ocular-surface stress is controlled. Some patients have much more complex persistent pain. And the natural history is not yet understood well enough to predict an individual patient’s outcome from the label alone.
So a diagnosis should help guide treatment. It should not be treated as a prediction of someone’s future.
Watson SL, Le DTM. Corneal Neuropathic Pain: A Review to Inform Clinical Practice.
Particularly useful overview of peripheral and central mechanisms, diagnosis, topical-anesthetic testing, IVCM and the overlap between dry eye and corneal neuropathic pain.
Anam A, et al. Blood-Derived Eye Drops for the Treatment of Corneal Neuropathic Pain.
Review of serum, PRP and related blood-derived preparations and the developing evidence concerning symptoms and corneal nerve changes.
Neuropathic Corneal Pain and Dry Eye: A Continuum of Nociception.
Review discussing the biological overlap between conventional dry-eye nociception and neuropathic corneal pain rather than treating them as completely unrelated entities.
TFOS DEWS III: Digest.
Updated TFOS framework recognizing that ocular pain perception depends on corneal nerve integrity and both peripheral and central nervous-system function.